Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dna X (SONM) Raw Materials (2018 - 2025)

Dna X (SONM) has disclosed Raw Materials for 8 consecutive years, with $8.1 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Raw Materials rose 23.51% year-over-year to $8.1 million, compared with a TTM value of $8.1 million through Sep 2025, up 23.51%, and an annual FY2024 reading of $5.6 million, up 645.41% over the prior year.
  • Raw Materials was $8.1 million for Q3 2025 at Dna X, up from $6.3 million in the prior quarter.
  • Across five years, Raw Materials topped out at $8.1 million in Q3 2025 and bottomed at $3000.0 in Q2 2023.
  • Average Raw Materials over 5 years is $2.6 million, with a median of $2.2 million recorded in 2021.
  • The sharpest move saw Raw Materials crashed 99.62% in 2023, then skyrocketed 77900.0% in 2024.
  • Year by year, Raw Materials stood at $2.0 million in 2021, then tumbled by 99.3% to $14000.0 in 2022, then skyrocketed by 5264.29% to $751000.0 in 2023, then soared by 645.41% to $5.6 million in 2024, then surged by 44.34% to $8.1 million in 2025.
  • Business Quant data shows Raw Materials for SONM at $8.1 million in Q3 2025, $6.3 million in Q2 2025, and $4.3 million in Q1 2025.